Press Releases.

June 07, 2016

Regulus Reports Positive Top-line Data

- Results Demonstrate First Successful Shortened 4-week Treatment Regimen to Date -
- Photos 1
June 03, 2016

Regulus to Present at the Jefferies 2016 Healthcare Conference
- Photos 1
June 02, 2016

Dr. Hugh Rosen Joins Regulus Board of Directors
- Photos 1
June 01, 2016

Regulus Expands Clinical Trial Collaboration with GSK

- Phase II Study Evaluating the Combination of RG-101 and GSK's Long-Acting Parenteral (LAP) Formulation of GSK2878175 as a potential single-visit cure to begin Q4 2016
- Photos 1
May 23, 2016

Regulus Appoints Allison Wey as Vice President, Investor Relations & Corporate Communications
- Photos 1

Show per page